Laser Photonics Announces Exercise of Warrants for $1.5 Million Gross Proceeds

Rhea-AI Summary

Laser Photonics (NASDAQ:LASE) announced a definitive agreement for immediate exercise of warrants to purchase up to 1,373,630 common shares at a reduced exercise price of $1.08 per share, generating approximately $1.5 million gross proceeds.

The Company will issue new unregistered Series A-3 and Series A-4 warrants covering the same number of shares; closing expected on or about March 17, 2026. Proceeds are intended for working capital and general corporate purposes; H.C. Wainwright is the exclusive placement agent.

Positive

• Gross proceeds of approximately $1.5 million
• Immediate cash inflow at a $1.08 exercise price
• Shares issuable registered under Form S-1 No. 333-290875

Negative

• Potential dilution from up to 1,373,630 new shares
• New Series A-3/A-4 warrants extend future dilution timelines
• Placement agent fees and offering expenses will reduce net proceeds

News Market Reaction – LASE

-11.94%

18 alerts

-11.94% Session close to close

-26.5% Trough in 4 hr 14 min

$32.31M Market Cap

0.5x Rel. Volume

In the Mar 16 session, LASE declined 11.94%, reflecting a significant negative market reaction. Argus tracked a trough of -26.5% from its starting point during tracking. Our momentum scanner triggered 18 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock dropped -11.9% in the session following this news. A negative reaction despite the cash in...

Analysis

The stock dropped -11.9% in the session following this news. A negative reaction despite the cash infusion fits the pattern from the February offering, which saw a -38.41% move after a $5.0 million unit sale. The warrant repricing to $1.08 and issuance of new Series A-3 and A-4 warrants increase potential dilution, and investors may have focused more on overhang risk than on the roughly $1.5 million in gross proceeds for working capital.

Key Figures

Gross proceeds: $1.5 million Original exercise price: $3.40 per share Reduced exercise price: $1.08 per share +5 more

8 metrics

Gross proceeds $1.5 million Expected from immediate warrant exercise before fees

Original exercise price $3.40 per share Exercise price for warrants issued September 2025

Reduced exercise price $1.08 per share New exercise price for repriced warrants and new Series A-3/A-4

Warrants exercised 1,373,630 warrants Outstanding warrants subject to immediate cash exercise

New Series A-3 warrants 1,373,630 shares Unregistered replacement warrants issued in private placement

New Series A-4 warrants 1,373,630 shares Additional unregistered warrants issued in private placement

A-3 warrant term 5 years Expires five years after stockholder approval/effective resale registration

A-4 warrant term 18 months Expires 18 months after stockholder approval/effective resale registration

Previous Offering Reports

1 past event · Latest: Feb 06 (Negative)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 06	Dilutive offering	Negative	-38.4%	Best-efforts $5M unit offering with A-1 and A-2 warrants at $0.70.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The last offering-related announcement on Feb 6, 2026 coincided with a sharp -38.41% one-day drop, suggesting investors previously reacted negatively to dilution and capital-raise structures.

Recent Company History

In early 2026, Laser Photonics completed a public offering detailed on Feb 6, 2026, issuing 7,142,858 common shares (or pre-funded warrants) with Series A-1 and A-2 warrants at $0.70 per unit for roughly $5.0 million in gross proceeds. That offering, involving multi-year warrants and warning of dilution and risk in related filings, led to a -38.41% 24-hour price reaction. Today’s warrant-exercise transaction continues the pattern of using equity-linked securities to raise working capital and fund operations.

Key Terms

warrants, exercise price, registration statement, form s-1, +2 more

6 terms

warrants financial

"announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants"

Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.

View in glossary

exercise price financial

"having an exercise price of $3.40 per share, at a reduced exercise price of $1.08 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

registration statement regulatory

"registered pursuant to an effective registration statement on Form S-1"

A registration statement is a formal document that companies file with a government agency to offer new shares of stock to the public. It provides essential information about the company's finances, operations, and risks, helping investors make informed decisions. Think of it as a detailed product description that ensures transparency and trust before buying into a company.

form s-1 regulatory

"registration statement on Form S-1 (No. 333-290875)"

A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.

private placement financial

"The new warrants described above were offered in a private placement pursuant to an applicable exemption"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

resale registration statement regulatory

"file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement")"

A resale registration statement is a document filed with regulators that allows existing shareholders to sell their shares to the public. It provides the necessary legal approval and information for these shares to be resold on the market, helping to increase the availability of shares for trading. For investors, it signals that shares held by current owners can be offered for sale, potentially affecting share prices and market liquidity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ORLANDO, FL / ACCESS Newswire / March 16, 2026 / Laser Photonics Corporation (NASDAQ:LASE) (the "Company"), a global leader in laser systems for industrial and defense applications, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 1,373,630 shares of common stock of the Company originally issued in September 2025, having an exercise price of $3.40 per share, at a reduced exercise price of $1.08 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-290875). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $1.5 million, prior to deducting placement agent fees and estimated offering expenses.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

In consideration for the immediate exercise of the warrants for cash, the Company will issue new unregistered Series A-3 warrants to purchase up to 1,373,630 shares of common stock and new unregistered Series A-4 warrants to purchase up to 1,373,630 shares of common stock. The new warrants will have an exercise price of $1.08 per share and will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares issuable upon exercise of the new warrants. The Series A-3 new warrants will expire five years after the later of (i) the date of stockholder approval and (ii) the effective date of the Resale Registration Statement (as defined below) and the Series A-4 new warrants will expire eighteen months after the later of (x) the date of stockholder approval and (y) the effective date of the Resale Registration Statement.

The offering is expected to close on or about March 17, 2026, subject to satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.

The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "1933 Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the 1933 Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement").

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Laser Photonics Corporation

Laser Photonics Corporation (NASDAQ:LASE) is a global leader in laser systems for industrial and defense applications. The Company develops and manufactures advanced laser technologies used in cleaning, surface preparation, and precision material processing across demanding operating environments. Laser Photonics serves a broad range of end markets, including defense and government, aerospace, energy, maritime, automotive, and advanced manufacturing. Through a combination of internal development, strategic acquisitions, and partnerships, the Company continues to expand its product portfolio and address new applications where performance, efficiency, and environmental considerations are critical. For more information, please visit https://laserphotonics.com.

Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering, the receipt of stockholder approval and the intended use of net proceeds from the offering. These statements are based on current expectations as of the date of this press release and involve a number of risks and uncertainties, which may cause results and uses of proceeds to differ materially from those indicated by these forward-looking statements. These risks include, without limitation, those described under the caption "Risk Factors" in our Form 10-K for the fiscal year ended December 31, 2024. Any reader of this press release is cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this press release except as required by applicable laws or regulations.

Investor Relations Contact:

Lucas A. Zimmerman & Ian Scargill
MZ Group - MZ North America
(262) 357-2918
LASE@mzgroup.us
www.mzgroup.us

SOURCE: Laser Photonics Corp.

View the original press release on ACCESS Newswire

FAQ

What did Laser Photonics (LASE) announce on March 16, 2026 regarding warrants?

They announced immediate exercise of warrants for up to 1,373,630 shares at $1.08 per share. According to the company, this will generate approximately $1.5 million gross proceeds prior to fees and expenses.

How will the March 2026 warrant exercise affect LASE shareholders?

It may dilute existing shareholders by up to 1,373,630 shares if all warrants are exercised. According to the company, new Series A-3 and A-4 warrants also create potential future dilution contingent on approval and exercise.

When is the offering expected to close for Laser Photonics (LASE)?

The offering is expected to close on or about March 17, 2026, subject to closing conditions. According to the company, customary closing conditions must be satisfied before funds are received.

What will Laser Photonics (LASE) use the proceeds from the warrant exercise for?

Proceeds are intended for working capital and general corporate purposes. According to the company, net proceeds after placement agent fees and expenses will fund ongoing corporate needs.

What are the terms of the new Series A-3 and A-4 warrants issued by LASE?

New Series A-3 and A-4 warrants cover up to 1,373,630 shares each with a $1.08 exercise price and differing expirations. According to the company, exercisability depends on stockholder approval and registration timing.